Success Metrics

Clinical Success Rate
100.0%

Based on 10 completed trials

Completion Rate
100%(10/10)
Active Trials
3(23%)
Results Posted
40%(4 trials)

Phase Distribution

Ph phase_1
1
8%
Ph phase_2
2
15%
Ph not_applicable
10
77%

Phase Distribution

1

Early Stage

2

Mid Stage

0

Late Stage

Phase Distribution13 total trials
Phase 1Safety & dosage
1(7.7%)
Phase 2Efficacy & side effects
2(15.4%)
N/ANon-phased studies
10(76.9%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

100.0%

10 of 10 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

3

trials recruiting

Total Trials

13

all time

Status Distribution
Active(3)
Completed(10)

Detailed Status

Completed10
Recruiting3

Development Timeline

Analytics

Development Status

Total Trials
13
Active
3
Success Rate
100.0%
Most Advanced
Phase 2

Trials by Phase

Phase 11 (7.7%)
Phase 22 (15.4%)
N/A10 (76.9%)

Trials by Status

recruiting323%
completed1077%

Recent Activity

Clinical Trials (13)

Drug Details

Intervention Type
BEHAVIORAL
Total Trials
13